OM336-AIC-1001
OM336-AIC-1001: An Open-Label, Phase 1b, Multiple Ascending Dose Study of OM336 in Participants with Active Autoimmune Cytopenias
Trial summary:
Receptor status / problem studied:
Inclusion criteria
Exclusion criteria
Open for recruitment
Trial Title
OM336-AIC-1001
Diagnosis
Immune Thrombocytopenia (ITP)
Type of trial
Pharmaceutical
Type of treatement
Haematology
Phase
I
Locations
Investigators
Principal Investigator